What are the different classifications of hypertensive disorders in pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Classification of Hypertensive Disorders in Pregnancy

The International Society for the Study of Hypertension in Pregnancy (ISSHP) provides the definitive classification system that divides hypertensive disorders into two main temporal categories: hypertension present before or in early pregnancy (before 20 weeks), and hypertension arising de novo at or after 20 weeks' gestation. 1

Primary Classification Framework

The ISSHP classification organizes hypertensive disorders based on timing and etiology:

Hypertension Known Before Pregnancy or Present in First 20 Weeks

Chronic Hypertension is defined as blood pressure ≥140/90 mmHg that either predates pregnancy or develops before 20 weeks' gestation. 2 This category subdivides into:

  • Essential hypertension - the most common form, typically accompanied by family history and often associated with overweight or obesity 1
  • Secondary hypertension - less common causes including primary renal parenchymal disorders (reflux nephropathy, glomerulonephritis), fibromuscular hyperplasia of renal arteries, or primary hyperaldosteronism 1

White-Coat Hypertension presents as elevated office/clinic BP (≥140/90 mmHg) but normal BP at home or work (<135/85 mmHg). 1, 3 This is not entirely benign and carries increased risk for preeclampsia, affecting up to 25% of patients with elevated clinic readings. 1, 4

Masked Hypertension is characterized by normal clinic BP but elevated readings at other times. 3

Hypertension Arising De Novo at or After 20 Weeks

Transient Gestational Hypertension develops at any gestation but resolves without treatment during pregnancy. 1 Despite its transient nature, this carries approximately 40% risk of subsequently developing gestational hypertension or preeclampsia later in the same pregnancy. 3, 4

Gestational Hypertension is persistent de novo hypertension developing at or after 20 weeks without features of preeclampsia. 1 The risk of complications depends critically on gestational age at onset, with approximately 20-25% progressing to preeclampsia. 4, 5

Preeclampsia is diagnosed when gestational hypertension is accompanied by one or more new-onset conditions including proteinuria (≥0.3 g/day or ≥30 mg/mmol urinary creatinine), renal insufficiency, liver involvement, neurological complications, hematological complications, or uteroplacental dysfunction at or after 20 weeks. 3, 2

Superimposed Preeclampsia occurs when preeclampsia develops on top of pre-existing chronic hypertension, complicating up to 25% of pregnancies with chronic hypertension. 1

Critical Diagnostic Thresholds

Hypertension is uniformly defined as systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg. 3, 4

Severe hypertension requires systolic BP ≥160 mmHg and/or diastolic BP ≥110 mmHg. 3, 4

Confirmation Requirements

  • For severe hypertension (≥160/110 mmHg): Confirmation must occur within 15 minutes with repeated measurements 3, 4
  • For less severe hypertension: Confirmation requires repeated readings over several hours on the same visit or on two consecutive antenatal visits 1, 4

Important Clinical Distinctions

The ISSHP explicitly recommends against using the term "severe preeclampsia" in clinical practice, instead describing preeclampsia as "with or without severe features." 1, 3 This terminology shift reflects more accurate risk stratification.

The 20-Week Gestational Cutoff

The 20-week threshold is critical for classification. 1 However, a common pitfall exists: normal BP first measured after 12 weeks may reflect the physiologic first-trimester BP decrease, potentially masking underlying chronic hypertension. 1 Therefore, prepregnancy or early first-trimester BP documentation is essential for accurate classification.

Ambulatory and Home BP Monitoring

Normal 24-hour ambulatory BP values before 22 weeks should be below:

  • 24-hour average: 126/76 mmHg
  • Awake average: 132/79 mmHg
  • Sleep average: 114/66 mmHg 1, 4

These thresholds are slightly lower than non-pregnant values. 1 Approximately 25% of automated home devices differ from standard sphygmomanometry, requiring validation against calibrated devices before clinical use. 1

Baseline Testing for Chronic Hypertension

All women with chronic hypertension require baseline testing at first diagnosis to facilitate later detection of superimposed preeclampsia:

  • Complete blood count (hemoglobin and platelet count)
  • Liver enzymes (AST, ALT, LDH) and function tests (INR, bilirubin, albumin)
  • Serum creatinine, electrolytes, and uric acid
  • Urinalysis with microscopy and protein-to-creatinine ratio or albumin-to-creatinine ratio
  • Renal ultrasound if serum creatinine or urine testing are abnormal 1, 3

Note that while elevated gestation-corrected uric acid associates with worse outcomes, it should not determine delivery timing. 1

Long-Term Implications

Women with any hypertensive disorder of pregnancy face significant long-term cardiovascular risks. 1 Annual medical review is advised lifelong, with goals including achieving prepregnancy weight by 12 months postpartum and maintaining healthy lifestyle through exercise and optimal body weight. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria for Hypertension in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Classification and Management of Hypertensive Disorders in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis of Gestational Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the definition, epidemiology, etiology, classification, risk factors, pathophysiology, clinical presentation, diagnosis, and treatment of hypertensive disorders of pregnancy?
What is the most appropriate initial management for an 18-year-old primigravid woman at 38 weeks' gestation with newly elevated blood pressure (hypertension), proteinuria, and symptoms suggestive of preeclampsia?
What is the best next step for a 35-week pregnant patient with preeclampsia, presenting with a severe headache, hypertension, and impaired renal function?
What are the Carpenter criteria for diagnosing and managing pregnancy-induced hypertension (PIH) in pregnant women?
How to manage a 36-week pregnant woman with significant proteinuria, normal blood pressure, and bilateral edema?
What is the long-term risk of seizures and need for antiepileptic medication, such as Keppra (levetiracetam), in a patient with a history of seizures post-mitral valve repair and maze procedure, and can they safely drive?
What is the differential diagnosis for a 21-year-old female with palpitations and diaphoresis (excessive sweating), and normal thyroid function?
Can a patient with severe anemia be discharged after two blood transfusions?
What is the best next step in managing a patient with multiple sclerosis relapse presenting with fatigue, bilateral leg weakness, and optic neuritis?
Do you need to stop Lucemyra (lofexidine) before starting Suboxone (buprenorphine/naloxone) for opioid detoxification?
What is the treatment for anxiety?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.